KFF Poll Shows Limited Public Awareness of Mifepristone Amid FDA Review

A KFF Health Tracking Poll finds limited public awareness of mifepristone safety and prevalence as the FDA conducts a re-review of the abortion medication. The poll, conducted in July 2026, shows that voters prioritizing abortion policy discussions in the 2026 midterm elections are disproportionately Democrats. The survey results come during an ongoing federal regulatory review process that could affect access to medication abortion. While mifepristone is used in some state Medicaid programs for covered abortion services, this poll focuses on general public awareness rather than Medicaid program operations or coverage policies.

Maternal